Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Verena Limperger

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Kinderkrankenschwester : Organ Der Sektion Kinderkrankenpflege|December 6, 2013
[Thromboembolisms in childhood and adolescence]Verena Limperger, Ulrike Nowak-Göttl
Hamostaseologie|February 3, 2015
End-stage renal disease and thrombophiliaAlexander Bauer, Verena Limperger, Ulrike Nowak-Göttl
Blood Cells, Molecules & Diseases|December 25, 2016
Risk factors for symptomatic venous and arterial thromboembolism in newborns, children and adolescents - What did we learn within the last 20years?Gili Kenet, Verena Limperger, Maria Shneyder, et al.
Thrombosis Research|April 24, 2015
Bleeding issues in neonates and infants - update 2015Ulrike Nowak-Göttl, Verena Limperger, Alexander Bauer, et al.
Neurosurgical Review|July 26, 2017
In vitro analysis of platelet function in acute aneurysmal subarachnoid haemorrhageChristian von der Brelie, Alexander Subai, Verena Limperger, et al.
Blood Cells, Molecules & Diseases|December 27, 2016
Developmental hemostasis: A lifespan from neonates and pregnancy to the young and elderly adult in a European white populationUlrike Nowak-Göttl, Verena Limperger, Gili Kenet, et al.
Blood Cells, Molecules & Diseases|November 21, 2016
Health-related quality of life in children, adolescents and adults with hereditary and acquired bleeding disordersUlrike Nowak-Göttl, Hartmut Clausnizer, Dorothee Kowalski, et al.
Thrombosis and Haemostasis|February 16, 2021
Single- and Multimarker Genome-Wide Scans Evidence Novel Genetic Risk Modifiers for Venous ThromboembolismMarisol Herrera-Rivero, Monika Stoll, Jana-Charlotte Hegenbarth, et al.
Thrombosis Research|February 4, 2014
Influence of factor 5 rs6025 and factor 2 rs1799963 mutation on inhibitor development in patients with hemophilia A--an Israeli-German multicenter database studyGili Kenet, Christoph Bidlingmaier, Nadja Bogdanova, et al.
British Journal of Haematology|June 23, 2016
Impact of high-risk thrombophilia status on recurrence among children with a first non-central-venous-catheter-associated VTE: an observational multicentre cohort studyVerena Limperger, Gili Kenet, Neil A Goldenberg, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Kinderkrankenschwester : Organ Der Sektion Kinderkrankenpflege|December 6, 2013
[Thromboembolisms in childhood and adolescence]Verena Limperger, Ulrike Nowak-Göttl
Hamostaseologie|February 3, 2015
End-stage renal disease and thrombophiliaAlexander Bauer, Verena Limperger, Ulrike Nowak-Göttl
Blood Cells, Molecules & Diseases|December 25, 2016
Risk factors for symptomatic venous and arterial thromboembolism in newborns, children and adolescents - What did we learn within the last 20years?Gili Kenet, Verena Limperger, Maria Shneyder, et al.
Thrombosis Research|April 24, 2015
Bleeding issues in neonates and infants - update 2015Ulrike Nowak-Göttl, Verena Limperger, Alexander Bauer, et al.
Neurosurgical Review|July 26, 2017
In vitro analysis of platelet function in acute aneurysmal subarachnoid haemorrhageChristian von der Brelie, Alexander Subai, Verena Limperger, et al.
Blood Cells, Molecules & Diseases|December 27, 2016
Developmental hemostasis: A lifespan from neonates and pregnancy to the young and elderly adult in a European white populationUlrike Nowak-Göttl, Verena Limperger, Gili Kenet, et al.
Blood Cells, Molecules & Diseases|November 21, 2016
Health-related quality of life in children, adolescents and adults with hereditary and acquired bleeding disordersUlrike Nowak-Göttl, Hartmut Clausnizer, Dorothee Kowalski, et al.
Thrombosis and Haemostasis|February 16, 2021
Single- and Multimarker Genome-Wide Scans Evidence Novel Genetic Risk Modifiers for Venous ThromboembolismMarisol Herrera-Rivero, Monika Stoll, Jana-Charlotte Hegenbarth, et al.
Thrombosis Research|February 4, 2014
Influence of factor 5 rs6025 and factor 2 rs1799963 mutation on inhibitor development in patients with hemophilia A--an Israeli-German multicenter database studyGili Kenet, Christoph Bidlingmaier, Nadja Bogdanova, et al.
British Journal of Haematology|June 23, 2016
Impact of high-risk thrombophilia status on recurrence among children with a first non-central-venous-catheter-associated VTE: an observational multicentre cohort studyVerena Limperger, Gili Kenet, Neil A Goldenberg, et al.
Pageof 2